Real-time index price for Nasdaq Composite [TR] (XCMP), along with buy or sell indicators, analysis, charts, historical ...

A groundbreaking achievement in brain-computer interface technology: an ALS patient uses a Neuralink implant to edit and narrate a YouTube video.

The third patient of Elon Musk's brain computer interface company Neuralink is using the billionaire's foul-mouthed AI ...

Interestingly, Smith is the first non-verbal individual and only the third person globally to receive a Neuralink Brain-Chip ...

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.

Clene’s cash and cash equivalents totaled $9.8 million as of March 31, 2025, compared to $12.2 million as of December 31, 2024. Clene expects that its resources as of March 31, 2025, will be ...

Prilenia, Ferrer entered collaboration agreement for commercialization and co-development of pridopidine in Europe and other ...

Houston mortgage duo Cissy and Christopher Larkin are channeling a four-year ALS battle into a widespread fundraiser.

Lilly licenses Alchemab’s ALS antibody ATLX-1282 in $415mn deal, expanding its neuroscience pipeline with a novel, ...

Eli Lilly (LLY) inks a licensing agreement with Alchemab to jointly develop an ALS drug in a $415M deal. Read more here.

Alchemab Therapeutics Ltd. has entered into a licensing agreement with Eli Lilly and Co. for ATLX-1282, Alchemab’s first-in-class IND-ready program targeting a novel receptor and mechanism for ...